![]() |
||
|
||
|
|
ASENT Advocacy ForumEach year, the ASENT Advocacy Forum presents an opportunity for in depth discussion of hot topics in neurotherapeutics development as identified by patient advocates. It is developed by the Advocacy Committee of ASENT, which seeks to facilitate advocate and advocacy organization participation in the Society and at Annual Meetings. ASENT and the advocacy groups share a common goal: to reduce barriers to therapeutics development and to smooth the path in bringing new treatments to patients. The leadership of ASENT is dedicated to building continuing relationships and encouraging communication with the advocacy community and has committed to supporting the ASENT Advocacy Forum as a free program that is open to the public. All stakeholders in the neurotherapeutics development are invited to attend. If you would like to register, please click here Join Us for ASENT's Seventh Annual Advocacy Forum Thursday, March 6, 2008 at the Crystal Gateway Marriott Hotel, Arlington, Virginia from 9:00am-Noon Topic: Patient-Reported Outcome Data: Will This Improve Therapeutic Development? Chair: Cynthia Joyce, SMA Foundation Topics will include:
Ron Bartek, Friedreich's Ataxia Research Alliance) Robert Griggs, M.D., University of Rochester Walter Koroschetz, M.D., NINDS Chris Leibman, Elan Pharmaceuticals, Inc. Toni Stifano, FDA; Center for Drug Evaluation and Research Information for Advocacy Groups
ASENT Advocacy CommitteeCynthia Joyce (Chair) SMA Foundation Judith Blazer WE MOVE Perry Cohen Ph.D. Parkinson Pipeline Project Robin Elliott Parkinson's Disease Foundation Jean Hubble Vernalis Rosalie Lewis Dystonia Medical Research Foundation Jill Rasmussen M.D. Psynapse Cynthia Rothblum-Oviatt Ph.D. A-T Children's Project |
|
|
|
|
|